nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.252	0.534	CrCtD
Eplerenone—Progesterone—uterine cancer	0.22	0.466	CrCtD
Eplerenone—NR3C2—Progesterone—uterine cancer	0.111	0.612	CbGbCtD
Eplerenone—Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.021	0.0726	CrCrCtD
Eplerenone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.02	0.0692	CrCrCtD
Eplerenone—Drospirenone—Progesterone—uterine cancer	0.0183	0.0633	CrCrCtD
Eplerenone—CYP3A7—Progesterone—uterine cancer	0.0174	0.0962	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0174	0.0962	CbGbCtD
Eplerenone—Spironolactone—Progesterone—uterine cancer	0.0174	0.0603	CrCrCtD
Eplerenone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.0147	0.0508	CrCrCtD
Eplerenone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.0142	0.0493	CrCrCtD
Eplerenone—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.0142	0.0491	CrCrCtD
Eplerenone—CYP3A5—Progesterone—uterine cancer	0.0131	0.0722	CbGbCtD
Eplerenone—Hydrocortamate—Progesterone—uterine cancer	0.0128	0.0443	CrCrCtD
Eplerenone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0127	0.0439	CrCrCtD
Eplerenone—Cortisone acetate—Progesterone—uterine cancer	0.0124	0.0429	CrCrCtD
Eplerenone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0124	0.0428	CrCrCtD
Eplerenone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.0124	0.0428	CrCrCtD
Eplerenone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.0124	0.0428	CrCrCtD
Eplerenone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0121	0.0417	CrCrCtD
Eplerenone—Fluoxymesterone—Progesterone—uterine cancer	0.0111	0.0383	CrCrCtD
Eplerenone—Testosterone Propionate—Progesterone—uterine cancer	0.0108	0.0373	CrCrCtD
Eplerenone—Fludrocortisone—Progesterone—uterine cancer	0.0108	0.0373	CrCrCtD
Eplerenone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0107	0.0371	CrCrCtD
Eplerenone—Methyltestosterone—Progesterone—uterine cancer	0.0105	0.0364	CrCrCtD
Eplerenone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0349	CrCrCtD
Eplerenone—Testosterone—Progesterone—uterine cancer	0.00936	0.0324	CrCrCtD
Eplerenone—Hydrocortisone—Progesterone—uterine cancer	0.0088	0.0304	CrCrCtD
Eplerenone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0077	0.0425	CbGbCtD
Eplerenone—CYP3A5—Etoposide—uterine cancer	0.00586	0.0323	CbGbCtD
Eplerenone—CYP3A4—Progesterone—uterine cancer	0.0051	0.0281	CbGbCtD
Eplerenone—CYP3A4—Etoposide—uterine cancer	0.00228	0.0126	CbGbCtD
Eplerenone—CYP3A4—Doxorubicin—uterine cancer	0.00156	0.00859	CbGbCtD
Eplerenone—CYP11B2—Glucocorticoid & Mineralcorticoid Metabolism—CYP11A1—uterine cancer	0.0013	0.0993	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.000966	0.0738	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.000698	0.0534	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.000698	0.0534	CbGpPWpGaD
Eplerenone—CYP11B2—Endogenous sterols—CYP11A1—uterine cancer	0.000558	0.0426	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.000418	0.0319	CbGpPWpGaD
Eplerenone—CYP11B2—Endogenous sterols—CYP19A1—uterine cancer	0.00041	0.0314	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000332	0.0254	CbGpPWpGaD
Eplerenone—CYP11B2—renal system—uterine cancer	0.000328	0.142	CbGeAlD
Eplerenone—CYP11B2—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.000307	0.0235	CbGpPWpGaD
Eplerenone—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	0.0003	0.191	CrCbGaD
Eplerenone—NR3C2—Preimplantation Embryo—HMGA1—uterine cancer	0.000299	0.0229	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000292	0.0223	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000259	0.0198	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000255	0.0195	CbGpPWpGaD
Eplerenone—Drospirenone—PGR—uterine cancer	0.00025	0.159	CrCbGaD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00021	0.0161	CbGpPWpGaD
Eplerenone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000206	0.0158	CbGpPWpGaD
Eplerenone—NR3C2—myometrium—uterine cancer	0.000199	0.0861	CbGeAlD
Eplerenone—CYP11B2—Metapathway biotransformation—AKR1B10—uterine cancer	0.000198	0.0151	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00019	0.0146	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000188	0.0144	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000184	0.0141	CbGpPWpGaD
Eplerenone—Spironolactone—PGR—uterine cancer	0.000178	0.113	CrCbGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.000177	0.0136	CbGpPWpGaD
Eplerenone—Medroxyprogesterone Acetate—PGR—uterine cancer	0.000167	0.106	CrCbGaD
Eplerenone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000159	0.0122	CbGpPWpGaD
Eplerenone—NR3C2—uterine cervix—uterine cancer	0.000155	0.067	CbGeAlD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000154	0.0118	CbGpPWpGaD
Eplerenone—CYP11B2—lymph node—uterine cancer	0.000154	0.0665	CbGeAlD
Eplerenone—NR3C2—smooth muscle tissue—uterine cancer	0.000151	0.0651	CbGeAlD
Eplerenone—NR3C2—renal system—uterine cancer	0.000145	0.0627	CbGeAlD
Eplerenone—NR3C2—endometrium—uterine cancer	0.00014	0.0606	CbGeAlD
Eplerenone—NR3C2—Preimplantation Embryo—CDH1—uterine cancer	0.000139	0.0106	CbGpPWpGaD
Eplerenone—NR3C2—mammalian vulva—uterine cancer	0.000136	0.0586	CbGeAlD
Eplerenone—CYP11B2—Metapathway biotransformation—AKR1C1—uterine cancer	0.000135	0.0103	CbGpPWpGaD
Eplerenone—NR3C2—uterus—uterine cancer	0.000129	0.0558	CbGeAlD
Eplerenone—Fluoxymesterone—ESR1—uterine cancer	0.000123	0.0781	CrCbGaD
Eplerenone—Testosterone—CYP11A1—uterine cancer	0.000121	0.0769	CrCbGaD
Eplerenone—CYP11B2—Metapathway biotransformation—GPX3—uterine cancer	0.000118	0.00906	CbGpPWpGaD
Eplerenone—NR3C2—female reproductive system—uterine cancer	0.000116	0.0502	CbGeAlD
Eplerenone—CYP11B2—Biological oxidations—CYP11A1—uterine cancer	0.000111	0.00853	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP11A1—uterine cancer	0.00011	0.00841	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00011	0.0084	CbGpPWpGaD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000108	0.00829	CbGpPWpGaD
Eplerenone—Methyltestosterone—CYP19A1—uterine cancer	0.000108	0.0686	CrCbGaD
Eplerenone—NR3C2—female gonad—uterine cancer	0.000106	0.0457	CbGeAlD
Eplerenone—Medroxyprogesterone Acetate—ESR1—uterine cancer	0.000105	0.067	CrCbGaD
Eplerenone—NR3C2—vagina—uterine cancer	0.000105	0.0454	CbGeAlD
Eplerenone—CYP11B2—Metapathway biotransformation—AKR1C3—uterine cancer	0.000104	0.00794	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.9e-05	0.00757	CbGpPWpGaD
Eplerenone—Progesterone—PGR—uterine cancer	9.63e-05	0.0613	CrCbGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.9e-05	0.00681	CbGpPWpGaD
Eplerenone—Body temperature increased—Progesterone—uterine cancer	8.6e-05	0.0021	CcSEcCtD
Eplerenone—Abdominal pain—Progesterone—uterine cancer	8.6e-05	0.0021	CcSEcCtD
Eplerenone—Hyperkalaemia—Epirubicin—uterine cancer	8.59e-05	0.0021	CcSEcCtD
Eplerenone—Renal failure—Etoposide—uterine cancer	8.58e-05	0.0021	CcSEcCtD
Eplerenone—Neuropathy peripheral—Etoposide—uterine cancer	8.56e-05	0.00209	CcSEcCtD
Eplerenone—Myocardial infarction—Etoposide—uterine cancer	8.56e-05	0.00209	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	8.51e-05	0.00208	CcSEcCtD
Eplerenone—Creatinine increased—Doxorubicin—uterine cancer	8.5e-05	0.00208	CcSEcCtD
Eplerenone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	8.5e-05	0.00208	CcSEcCtD
Eplerenone—Malaise—Dactinomycin—uterine cancer	8.5e-05	0.00208	CcSEcCtD
Eplerenone—Influenza like illness—Epirubicin—uterine cancer	8.49e-05	0.00208	CcSEcCtD
Eplerenone—Constipation—Medroxyprogesterone Acetate—uterine cancer	8.43e-05	0.00206	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—AKR1B10—uterine cancer	8.38e-05	0.00641	CbGpPWpGaD
Eplerenone—CYP3A5—uterine cervix—uterine cancer	8.37e-05	0.0362	CbGeAlD
Eplerenone—Blood urea increased—Epirubicin—uterine cancer	8.26e-05	0.00202	CcSEcCtD
Eplerenone—Hepatobiliary disease—Etoposide—uterine cancer	8.26e-05	0.00202	CcSEcCtD
Eplerenone—Blood uric acid increased—Doxorubicin—uterine cancer	8.24e-05	0.00201	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP19A1—uterine cancer	8.2e-05	0.00627	CbGpPWpGaD
Eplerenone—Musculoskeletal pain—Doxorubicin—uterine cancer	8.19e-05	0.002	CcSEcCtD
Eplerenone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	8.13e-05	0.00199	CcSEcCtD
Eplerenone—Ventricular tachycardia—Doxorubicin—uterine cancer	8.09e-05	0.00198	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP19A1—uterine cancer	8.09e-05	0.00619	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	8.08e-05	0.00618	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	8.06e-05	0.00197	CcSEcCtD
Eplerenone—Myalgia—Dactinomycin—uterine cancer	8.02e-05	0.00196	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.97e-05	0.0061	CbGpPWpGaD
Eplerenone—Hyperkalaemia—Doxorubicin—uterine cancer	7.95e-05	0.00194	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	7.94e-05	0.00607	CbGpPWpGaD
Eplerenone—Discomfort—Dactinomycin—uterine cancer	7.93e-05	0.00194	CcSEcCtD
Eplerenone—Influenza like illness—Doxorubicin—uterine cancer	7.86e-05	0.00192	CcSEcCtD
Eplerenone—CYP3A5—renal system—uterine cancer	7.83e-05	0.0339	CbGeAlD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	7.83e-05	0.00599	CbGpPWpGaD
Eplerenone—Asthenia—Progesterone—uterine cancer	7.81e-05	0.00191	CcSEcCtD
Eplerenone—Hypoaesthesia—Etoposide—uterine cancer	7.8e-05	0.0019	CcSEcCtD
Eplerenone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	7.8e-05	0.0019	CcSEcCtD
Eplerenone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	7.8e-05	0.0019	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—AKR1B1—uterine cancer	7.79e-05	0.00596	CbGpPWpGaD
Eplerenone—Pulmonary oedema—Epirubicin—uterine cancer	7.79e-05	0.0019	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—PHF1—uterine cancer	7.78e-05	0.00595	CbGpPWpGaD
Eplerenone—Urinary tract disorder—Etoposide—uterine cancer	7.74e-05	0.00189	CcSEcCtD
Eplerenone—Pruritus—Progesterone—uterine cancer	7.7e-05	0.00188	CcSEcCtD
Eplerenone—Urethral disorder—Etoposide—uterine cancer	7.68e-05	0.00188	CcSEcCtD
Eplerenone—Infection—Dactinomycin—uterine cancer	7.64e-05	0.00187	CcSEcCtD
Eplerenone—Blood urea increased—Doxorubicin—uterine cancer	7.64e-05	0.00187	CcSEcCtD
Eplerenone—Diarrhoea—Progesterone—uterine cancer	7.45e-05	0.00182	CcSEcCtD
Eplerenone—Diabetes mellitus—Epirubicin—uterine cancer	7.3e-05	0.00178	CcSEcCtD
Eplerenone—Cardiac disorder—Etoposide—uterine cancer	7.27e-05	0.00178	CcSEcCtD
Eplerenone—Flushing—Etoposide—uterine cancer	7.27e-05	0.00178	CcSEcCtD
Eplerenone—Pulmonary oedema—Doxorubicin—uterine cancer	7.2e-05	0.00176	CcSEcCtD
Eplerenone—Dizziness—Progesterone—uterine cancer	7.2e-05	0.00176	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.15e-05	0.00547	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.15e-05	0.00547	CbGpPWpGaD
Eplerenone—Angiopathy—Etoposide—uterine cancer	7.11e-05	0.00174	CcSEcCtD
Eplerenone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	7.08e-05	0.00173	CcSEcCtD
Eplerenone—Mediastinal disorder—Etoposide—uterine cancer	7.06e-05	0.00173	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	7.01e-05	0.00171	CcSEcCtD
Eplerenone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	6.98e-05	0.0017	CcSEcCtD
Eplerenone—Vomiting—Progesterone—uterine cancer	6.92e-05	0.00169	CcSEcCtD
Eplerenone—Rash—Progesterone—uterine cancer	6.86e-05	0.00168	CcSEcCtD
Eplerenone—Dermatitis—Progesterone—uterine cancer	6.86e-05	0.00167	CcSEcCtD
Eplerenone—Headache—Progesterone—uterine cancer	6.82e-05	0.00167	CcSEcCtD
Eplerenone—NR3C2—lymph node—uterine cancer	6.79e-05	0.0294	CbGeAlD
Eplerenone—Diabetes mellitus—Doxorubicin—uterine cancer	6.75e-05	0.00165	CcSEcCtD
Eplerenone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	6.75e-05	0.00165	CcSEcCtD
Eplerenone—Renal impairment—Epirubicin—uterine cancer	6.67e-05	0.00163	CcSEcCtD
Eplerenone—Fatigue—Dactinomycin—uterine cancer	6.63e-05	0.00162	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—CHD4—uterine cancer	6.61e-05	0.00506	CbGpPWpGaD
Eplerenone—Back pain—Etoposide—uterine cancer	6.6e-05	0.00161	CcSEcCtD
Eplerenone—Pain—Dactinomycin—uterine cancer	6.58e-05	0.00161	CcSEcCtD
Eplerenone—Muscle spasms—Etoposide—uterine cancer	6.56e-05	0.0016	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.55e-05	0.00501	CbGpPWpGaD
Eplerenone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	6.52e-05	0.00159	CcSEcCtD
Eplerenone—Nausea—Progesterone—uterine cancer	6.46e-05	0.00158	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	6.43e-05	0.00492	CbGpPWpGaD
Eplerenone—Hyponatraemia—Epirubicin—uterine cancer	6.38e-05	0.00156	CcSEcCtD
Eplerenone—Feeling abnormal—Dactinomycin—uterine cancer	6.34e-05	0.00155	CcSEcCtD
Eplerenone—Ill-defined disorder—Etoposide—uterine cancer	6.33e-05	0.00155	CcSEcCtD
Eplerenone—Anaemia—Etoposide—uterine cancer	6.31e-05	0.00154	CcSEcCtD
Eplerenone—Gastrointestinal pain—Dactinomycin—uterine cancer	6.29e-05	0.00154	CcSEcCtD
Eplerenone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	6.27e-05	0.00153	CcSEcCtD
Eplerenone—Testosterone—CYP19A1—uterine cancer	6.24e-05	0.0398	CrCbGaD
Eplerenone—Rash—Medroxyprogesterone Acetate—uterine cancer	6.22e-05	0.00152	CcSEcCtD
Eplerenone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	6.21e-05	0.00152	CcSEcCtD
Eplerenone—Headache—Medroxyprogesterone Acetate—uterine cancer	6.18e-05	0.00151	CcSEcCtD
Eplerenone—Renal impairment—Doxorubicin—uterine cancer	6.17e-05	0.00151	CcSEcCtD
Eplerenone—Malaise—Etoposide—uterine cancer	6.15e-05	0.0015	CcSEcCtD
Eplerenone—Abdominal pain—Dactinomycin—uterine cancer	6.08e-05	0.00149	CcSEcCtD
Eplerenone—Body temperature increased—Dactinomycin—uterine cancer	6.08e-05	0.00149	CcSEcCtD
Eplerenone—Progesterone—ESR1—uterine cancer	6.08e-05	0.0387	CrCbGaD
Eplerenone—CYP3A5—Metapathway biotransformation—AKR1B10—uterine cancer	6.06e-05	0.00463	CbGpPWpGaD
Eplerenone—Loss of consciousness—Etoposide—uterine cancer	6e-05	0.00146	CcSEcCtD
Eplerenone—Cough—Etoposide—uterine cancer	5.95e-05	0.00145	CcSEcCtD
Eplerenone—Blood creatinine increased—Epirubicin—uterine cancer	5.95e-05	0.00145	CcSEcCtD
Eplerenone—Dehydration—Epirubicin—uterine cancer	5.9e-05	0.00144	CcSEcCtD
Eplerenone—Hyponatraemia—Doxorubicin—uterine cancer	5.9e-05	0.00144	CcSEcCtD
Eplerenone—CYP3A4—renal system—uterine cancer	5.88e-05	0.0254	CbGeAlD
Eplerenone—Nausea—Medroxyprogesterone Acetate—uterine cancer	5.86e-05	0.00143	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	5.84e-05	0.00447	CbGpPWpGaD
Eplerenone—Chest pain—Etoposide—uterine cancer	5.81e-05	0.00142	CcSEcCtD
Eplerenone—Orthostatic hypotension—Epirubicin—uterine cancer	5.8e-05	0.00142	CcSEcCtD
Eplerenone—Hypokalaemia—Epirubicin—uterine cancer	5.78e-05	0.00141	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	5.77e-05	0.00141	CcSEcCtD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.76e-05	0.00441	CbGpPWpGaD
Eplerenone—Discomfort—Etoposide—uterine cancer	5.74e-05	0.0014	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—PGR—uterine cancer	5.73e-05	0.00438	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—AKR1C1—uterine cancer	5.72e-05	0.00438	CbGpPWpGaD
Eplerenone—Aspartate aminotransferase increased—Epirubicin—uterine cancer	5.72e-05	0.0014	CcSEcCtD
Eplerenone—CYP3A5—female gonad—uterine cancer	5.71e-05	0.0247	CbGeAlD
Eplerenone—CYP3A5—vagina—uterine cancer	5.67e-05	0.0245	CbGeAlD
Eplerenone—CYP3A5—Metapathway biotransformation—AKR1B1—uterine cancer	5.63e-05	0.00431	CbGpPWpGaD
Eplerenone—Alanine aminotransferase increased—Epirubicin—uterine cancer	5.6e-05	0.00137	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—SUZ12—uterine cancer	5.54e-05	0.00424	CbGpPWpGaD
Eplerenone—Infection—Etoposide—uterine cancer	5.53e-05	0.00135	CcSEcCtD
Eplerenone—Asthenia—Dactinomycin—uterine cancer	5.52e-05	0.00135	CcSEcCtD
Eplerenone—Blood creatinine increased—Doxorubicin—uterine cancer	5.5e-05	0.00134	CcSEcCtD
Eplerenone—Dehydration—Doxorubicin—uterine cancer	5.46e-05	0.00133	CcSEcCtD
Eplerenone—Eosinophilia—Epirubicin—uterine cancer	5.43e-05	0.00133	CcSEcCtD
Eplerenone—Skin disorder—Etoposide—uterine cancer	5.41e-05	0.00132	CcSEcCtD
Eplerenone—Hyperhidrosis—Etoposide—uterine cancer	5.38e-05	0.00131	CcSEcCtD
Eplerenone—Orthostatic hypotension—Doxorubicin—uterine cancer	5.37e-05	0.00131	CcSEcCtD
Eplerenone—Hypokalaemia—Doxorubicin—uterine cancer	5.35e-05	0.00131	CcSEcCtD
Eplerenone—Angina pectoris—Epirubicin—uterine cancer	5.35e-05	0.00131	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	5.29e-05	0.00129	CcSEcCtD
Eplerenone—Bronchitis—Epirubicin—uterine cancer	5.28e-05	0.00129	CcSEcCtD
Eplerenone—Diarrhoea—Dactinomycin—uterine cancer	5.26e-05	0.00129	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.25e-05	0.00402	CbGpPWpGaD
Eplerenone—Hypotension—Etoposide—uterine cancer	5.2e-05	0.00127	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	5.18e-05	0.00127	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Epirubicin—uterine cancer	5.1e-05	0.00125	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—ESR2—uterine cancer	5.05e-05	0.00386	CbGpPWpGaD
Eplerenone—Eosinophilia—Doxorubicin—uterine cancer	5.03e-05	0.00123	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—GPX3—uterine cancer	5.02e-05	0.00384	CbGpPWpGaD
Eplerenone—Dyspnoea—Etoposide—uterine cancer	4.96e-05	0.00121	CcSEcCtD
Eplerenone—Hyperglycaemia—Epirubicin—uterine cancer	4.95e-05	0.00121	CcSEcCtD
Eplerenone—Angina pectoris—Doxorubicin—uterine cancer	4.95e-05	0.00121	CcSEcCtD
Eplerenone—Pneumonia—Epirubicin—uterine cancer	4.92e-05	0.0012	CcSEcCtD
Eplerenone—Infestation NOS—Epirubicin—uterine cancer	4.89e-05	0.0012	CcSEcCtD
Eplerenone—Infestation—Epirubicin—uterine cancer	4.89e-05	0.0012	CcSEcCtD
Eplerenone—Vomiting—Dactinomycin—uterine cancer	4.89e-05	0.00119	CcSEcCtD
Eplerenone—Bronchitis—Doxorubicin—uterine cancer	4.88e-05	0.00119	CcSEcCtD
Eplerenone—Rash—Dactinomycin—uterine cancer	4.85e-05	0.00118	CcSEcCtD
Eplerenone—Renal failure—Epirubicin—uterine cancer	4.81e-05	0.00118	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Etoposide—uterine cancer	4.81e-05	0.00117	CcSEcCtD
Eplerenone—Fatigue—Etoposide—uterine cancer	4.8e-05	0.00117	CcSEcCtD
Eplerenone—Neuropathy peripheral—Epirubicin—uterine cancer	4.8e-05	0.00117	CcSEcCtD
Eplerenone—Pain—Etoposide—uterine cancer	4.76e-05	0.00116	CcSEcCtD
Eplerenone—Constipation—Etoposide—uterine cancer	4.76e-05	0.00116	CcSEcCtD
Eplerenone—Urinary tract infection—Epirubicin—uterine cancer	4.76e-05	0.00116	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.73e-05	0.00362	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP11A1—uterine cancer	4.73e-05	0.00362	CbGpPWpGaD
Eplerenone—Upper respiratory tract infection—Doxorubicin—uterine cancer	4.72e-05	0.00115	CcSEcCtD
Eplerenone—CYP3A4—female reproductive system—uterine cancer	4.71e-05	0.0204	CbGeAlD
Eplerenone—Haematuria—Epirubicin—uterine cancer	4.67e-05	0.00114	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP11A1—uterine cancer	4.66e-05	0.00357	CbGpPWpGaD
Eplerenone—Hepatobiliary disease—Epirubicin—uterine cancer	4.63e-05	0.00113	CcSEcCtD
Eplerenone—Feeling abnormal—Etoposide—uterine cancer	4.59e-05	0.00112	CcSEcCtD
Eplerenone—Hyperglycaemia—Doxorubicin—uterine cancer	4.58e-05	0.00112	CcSEcCtD
Eplerenone—Nausea—Dactinomycin—uterine cancer	4.57e-05	0.00112	CcSEcCtD
Eplerenone—Pneumonia—Doxorubicin—uterine cancer	4.55e-05	0.00111	CcSEcCtD
Eplerenone—Gastrointestinal pain—Etoposide—uterine cancer	4.55e-05	0.00111	CcSEcCtD
Eplerenone—Infestation—Doxorubicin—uterine cancer	4.53e-05	0.00111	CcSEcCtD
Eplerenone—Infestation NOS—Doxorubicin—uterine cancer	4.53e-05	0.00111	CcSEcCtD
Eplerenone—Renal failure—Doxorubicin—uterine cancer	4.45e-05	0.00109	CcSEcCtD
Eplerenone—Neuropathy peripheral—Doxorubicin—uterine cancer	4.44e-05	0.00108	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—SRD5A2—uterine cancer	4.41e-05	0.00337	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NDUFB11—uterine cancer	4.41e-05	0.00337	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—AKR1C3—uterine cancer	4.4e-05	0.00337	CbGpPWpGaD
Eplerenone—Body temperature increased—Etoposide—uterine cancer	4.4e-05	0.00108	CcSEcCtD
Eplerenone—Abdominal pain—Etoposide—uterine cancer	4.4e-05	0.00108	CcSEcCtD
Eplerenone—Urinary tract infection—Doxorubicin—uterine cancer	4.4e-05	0.00108	CcSEcCtD
Eplerenone—Hypoaesthesia—Epirubicin—uterine cancer	4.37e-05	0.00107	CcSEcCtD
Eplerenone—Pharyngitis—Epirubicin—uterine cancer	4.36e-05	0.00107	CcSEcCtD
Eplerenone—Urinary tract disorder—Epirubicin—uterine cancer	4.34e-05	0.00106	CcSEcCtD
Eplerenone—Oedema peripheral—Epirubicin—uterine cancer	4.33e-05	0.00106	CcSEcCtD
Eplerenone—Haematuria—Doxorubicin—uterine cancer	4.32e-05	0.00105	CcSEcCtD
Eplerenone—Connective tissue disorder—Epirubicin—uterine cancer	4.32e-05	0.00105	CcSEcCtD
Eplerenone—Urethral disorder—Epirubicin—uterine cancer	4.31e-05	0.00105	CcSEcCtD
Eplerenone—Hepatobiliary disease—Doxorubicin—uterine cancer	4.28e-05	0.00105	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.28e-05	0.00327	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	4.13e-05	0.00316	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—CDKN2B—uterine cancer	4.11e-05	0.00314	CbGpPWpGaD
Eplerenone—Tinnitus—Epirubicin—uterine cancer	4.1e-05	0.001	CcSEcCtD
Eplerenone—Flushing—Epirubicin—uterine cancer	4.08e-05	0.000996	CcSEcCtD
Eplerenone—Cardiac disorder—Epirubicin—uterine cancer	4.08e-05	0.000996	CcSEcCtD
Eplerenone—Hypoaesthesia—Doxorubicin—uterine cancer	4.04e-05	0.000988	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.04e-05	0.00309	CbGpPWpGaD
Eplerenone—Pharyngitis—Doxorubicin—uterine cancer	4.03e-05	0.000985	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—uterine cancer	4.01e-05	0.000981	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—uterine cancer	4e-05	0.000978	CcSEcCtD
Eplerenone—Asthenia—Etoposide—uterine cancer	3.99e-05	0.000976	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—uterine cancer	3.99e-05	0.000976	CcSEcCtD
Eplerenone—Angiopathy—Epirubicin—uterine cancer	3.99e-05	0.000974	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—uterine cancer	3.98e-05	0.000973	CcSEcCtD
Eplerenone—Mediastinal disorder—Epirubicin—uterine cancer	3.96e-05	0.000967	CcSEcCtD
Eplerenone—Pruritus—Etoposide—uterine cancer	3.94e-05	0.000962	CcSEcCtD
Eplerenone—Mental disorder—Epirubicin—uterine cancer	3.85e-05	0.00094	CcSEcCtD
Eplerenone—Malnutrition—Epirubicin—uterine cancer	3.82e-05	0.000934	CcSEcCtD
Eplerenone—Diarrhoea—Etoposide—uterine cancer	3.81e-05	0.000931	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—uterine cancer	3.79e-05	0.000926	CcSEcCtD
Eplerenone—Cardiac disorder—Doxorubicin—uterine cancer	3.77e-05	0.000922	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—uterine cancer	3.77e-05	0.000922	CcSEcCtD
Eplerenone—Flatulence—Epirubicin—uterine cancer	3.77e-05	0.000921	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—SMAD3—uterine cancer	3.75e-05	0.00287	CbGpPWpGaD
Eplerenone—Back pain—Epirubicin—uterine cancer	3.7e-05	0.000904	CcSEcCtD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	3.69e-05	0.00282	CbGpPWpGaD
Eplerenone—Angiopathy—Doxorubicin—uterine cancer	3.69e-05	0.000901	CcSEcCtD
Eplerenone—Dizziness—Etoposide—uterine cancer	3.68e-05	0.000899	CcSEcCtD
Eplerenone—Muscle spasms—Epirubicin—uterine cancer	3.68e-05	0.000898	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—uterine cancer	3.66e-05	0.000895	CcSEcCtD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	3.64e-05	0.00279	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	3.63e-05	0.00278	CbGpPWpGaD
Eplerenone—Mental disorder—Doxorubicin—uterine cancer	3.56e-05	0.00087	CcSEcCtD
Eplerenone—Ill-defined disorder—Epirubicin—uterine cancer	3.55e-05	0.000867	CcSEcCtD
Eplerenone—Vomiting—Etoposide—uterine cancer	3.54e-05	0.000865	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—uterine cancer	3.54e-05	0.000864	CcSEcCtD
Eplerenone—Anaemia—Epirubicin—uterine cancer	3.53e-05	0.000863	CcSEcCtD
Eplerenone—Rash—Etoposide—uterine cancer	3.51e-05	0.000858	CcSEcCtD
Eplerenone—Dermatitis—Etoposide—uterine cancer	3.51e-05	0.000857	CcSEcCtD
Eplerenone—Headache—Etoposide—uterine cancer	3.49e-05	0.000852	CcSEcCtD
Eplerenone—Flatulence—Doxorubicin—uterine cancer	3.49e-05	0.000852	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—CYP19A1—uterine cancer	3.48e-05	0.00266	CbGpPWpGaD
Eplerenone—Malaise—Epirubicin—uterine cancer	3.45e-05	0.000842	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP19A1—uterine cancer	3.43e-05	0.00262	CbGpPWpGaD
Eplerenone—Syncope—Epirubicin—uterine cancer	3.43e-05	0.000838	CcSEcCtD
Eplerenone—Back pain—Doxorubicin—uterine cancer	3.42e-05	0.000836	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	3.42e-05	0.00261	CbGpPWpGaD
Eplerenone—Muscle spasms—Doxorubicin—uterine cancer	3.4e-05	0.000831	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	3.37e-05	0.00258	CbGpPWpGaD
Eplerenone—Loss of consciousness—Epirubicin—uterine cancer	3.36e-05	0.000821	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	3.36e-05	0.00257	CbGpPWpGaD
Eplerenone—Cough—Epirubicin—uterine cancer	3.34e-05	0.000815	CcSEcCtD
Eplerenone—Nausea—Etoposide—uterine cancer	3.31e-05	0.000808	CcSEcCtD
Eplerenone—Ill-defined disorder—Doxorubicin—uterine cancer	3.28e-05	0.000802	CcSEcCtD
Eplerenone—Anaemia—Doxorubicin—uterine cancer	3.27e-05	0.000799	CcSEcCtD
Eplerenone—Chest pain—Epirubicin—uterine cancer	3.26e-05	0.000795	CcSEcCtD
Eplerenone—Arthralgia—Epirubicin—uterine cancer	3.26e-05	0.000795	CcSEcCtD
Eplerenone—Myalgia—Epirubicin—uterine cancer	3.26e-05	0.000795	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	3.23e-05	0.00079	CcSEcCtD
Eplerenone—Discomfort—Epirubicin—uterine cancer	3.22e-05	0.000786	CcSEcCtD
Eplerenone—Malaise—Doxorubicin—uterine cancer	3.19e-05	0.000779	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—STAR—uterine cancer	3.19e-05	0.00244	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AKR1B1—uterine cancer	3.19e-05	0.00244	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	3.18e-05	0.00243	CbGpPWpGaD
Eplerenone—Syncope—Doxorubicin—uterine cancer	3.17e-05	0.000775	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.15e-05	0.00241	CbGpPWpGaD
Eplerenone—Loss of consciousness—Doxorubicin—uterine cancer	3.11e-05	0.00076	CcSEcCtD
Eplerenone—Infection—Epirubicin—uterine cancer	3.1e-05	0.000757	CcSEcCtD
Eplerenone—Cough—Doxorubicin—uterine cancer	3.09e-05	0.000754	CcSEcCtD
Eplerenone—Shock—Epirubicin—uterine cancer	3.07e-05	0.00075	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—ESR1—uterine cancer	3.06e-05	0.00234	CbGpPWpGaD
Eplerenone—Nervous system disorder—Epirubicin—uterine cancer	3.06e-05	0.000748	CcSEcCtD
Eplerenone—Skin disorder—Epirubicin—uterine cancer	3.03e-05	0.000741	CcSEcCtD
Eplerenone—Hyperhidrosis—Epirubicin—uterine cancer	3.02e-05	0.000737	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—uterine cancer	3.01e-05	0.000736	CcSEcCtD
Eplerenone—Myalgia—Doxorubicin—uterine cancer	3.01e-05	0.000736	CcSEcCtD
Eplerenone—Arthralgia—Doxorubicin—uterine cancer	3.01e-05	0.000736	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	2.99e-05	0.000731	CcSEcCtD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	2.99e-05	0.00229	CbGpPWpGaD
Eplerenone—Discomfort—Doxorubicin—uterine cancer	2.98e-05	0.000727	CcSEcCtD
Eplerenone—Hypotension—Epirubicin—uterine cancer	2.92e-05	0.000712	CcSEcCtD
Eplerenone—Infection—Doxorubicin—uterine cancer	2.87e-05	0.000701	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Epirubicin—uterine cancer	2.84e-05	0.000695	CcSEcCtD
Eplerenone—Shock—Doxorubicin—uterine cancer	2.84e-05	0.000694	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—uterine cancer	2.83e-05	0.000692	CcSEcCtD
Eplerenone—Insomnia—Epirubicin—uterine cancer	2.82e-05	0.00069	CcSEcCtD
Eplerenone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	2.82e-05	0.00215	CbGpPWpGaD
Eplerenone—Skin disorder—Doxorubicin—uterine cancer	2.8e-05	0.000685	CcSEcCtD
Eplerenone—Hyperhidrosis—Doxorubicin—uterine cancer	2.79e-05	0.000682	CcSEcCtD
Eplerenone—Dyspnoea—Epirubicin—uterine cancer	2.78e-05	0.00068	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—PGR—uterine cancer	2.76e-05	0.00211	CbGpPWpGaD
Eplerenone—Dyspepsia—Epirubicin—uterine cancer	2.75e-05	0.000671	CcSEcCtD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	2.71e-05	0.00208	CbGpPWpGaD
Eplerenone—Hypotension—Doxorubicin—uterine cancer	2.7e-05	0.000659	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Epirubicin—uterine cancer	2.69e-05	0.000658	CcSEcCtD
Eplerenone—Fatigue—Epirubicin—uterine cancer	2.69e-05	0.000657	CcSEcCtD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	2.68e-05	0.00205	CbGpPWpGaD
Eplerenone—Pain—Epirubicin—uterine cancer	2.67e-05	0.000652	CcSEcCtD
Eplerenone—Constipation—Epirubicin—uterine cancer	2.67e-05	0.000652	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	2.63e-05	0.000643	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—EZH2—uterine cancer	2.62e-05	0.00201	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	2.62e-05	0.002	CbGpPWpGaD
Eplerenone—Insomnia—Doxorubicin—uterine cancer	2.61e-05	0.000638	CcSEcCtD
Eplerenone—Dyspnoea—Doxorubicin—uterine cancer	2.57e-05	0.000629	CcSEcCtD
Eplerenone—Feeling abnormal—Epirubicin—uterine cancer	2.57e-05	0.000628	CcSEcCtD
Eplerenone—Gastrointestinal pain—Epirubicin—uterine cancer	2.55e-05	0.000623	CcSEcCtD
Eplerenone—Dyspepsia—Doxorubicin—uterine cancer	2.54e-05	0.000621	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	2.51e-05	0.00192	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—POLD1—uterine cancer	2.5e-05	0.00191	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.49e-05	0.000609	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—uterine cancer	2.49e-05	0.000608	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	2.48e-05	0.0019	CbGpPWpGaD
Eplerenone—Pain—Doxorubicin—uterine cancer	2.47e-05	0.000603	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—uterine cancer	2.47e-05	0.000603	CcSEcCtD
Eplerenone—Body temperature increased—Epirubicin—uterine cancer	2.47e-05	0.000603	CcSEcCtD
Eplerenone—Abdominal pain—Epirubicin—uterine cancer	2.47e-05	0.000603	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—ESR2—uterine cancer	2.43e-05	0.00186	CbGpPWpGaD
Eplerenone—Feeling abnormal—Doxorubicin—uterine cancer	2.38e-05	0.000581	CcSEcCtD
Eplerenone—Gastrointestinal pain—Doxorubicin—uterine cancer	2.36e-05	0.000577	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—AKR1C1—uterine cancer	2.34e-05	0.00179	CbGpPWpGaD
Eplerenone—Abdominal pain—Doxorubicin—uterine cancer	2.28e-05	0.000558	CcSEcCtD
Eplerenone—Body temperature increased—Doxorubicin—uterine cancer	2.28e-05	0.000558	CcSEcCtD
Eplerenone—Asthenia—Epirubicin—uterine cancer	2.24e-05	0.000547	CcSEcCtD
Eplerenone—Pruritus—Epirubicin—uterine cancer	2.21e-05	0.000539	CcSEcCtD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.2e-05	0.00168	CbGpPWpGaD
Eplerenone—Diarrhoea—Epirubicin—uterine cancer	2.14e-05	0.000522	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—RRM2—uterine cancer	2.08e-05	0.00159	CbGpPWpGaD
Eplerenone—Asthenia—Doxorubicin—uterine cancer	2.07e-05	0.000506	CcSEcCtD
Eplerenone—Dizziness—Epirubicin—uterine cancer	2.06e-05	0.000504	CcSEcCtD
Eplerenone—Pruritus—Doxorubicin—uterine cancer	2.04e-05	0.000499	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—DCN—uterine cancer	2.02e-05	0.00155	CbGpPWpGaD
Eplerenone—Vomiting—Epirubicin—uterine cancer	1.98e-05	0.000485	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—CDKN2B—uterine cancer	1.98e-05	0.00151	CbGpPWpGaD
Eplerenone—Diarrhoea—Doxorubicin—uterine cancer	1.98e-05	0.000483	CcSEcCtD
Eplerenone—Rash—Epirubicin—uterine cancer	1.97e-05	0.000481	CcSEcCtD
Eplerenone—Dermatitis—Epirubicin—uterine cancer	1.97e-05	0.00048	CcSEcCtD
Eplerenone—Headache—Epirubicin—uterine cancer	1.96e-05	0.000478	CcSEcCtD
Eplerenone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.92e-05	0.00147	CbGpPWpGaD
Eplerenone—Dizziness—Doxorubicin—uterine cancer	1.91e-05	0.000466	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—CYP11A1—uterine cancer	1.91e-05	0.00146	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NDUFB11—uterine cancer	1.87e-05	0.00143	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SRD5A2—uterine cancer	1.87e-05	0.00143	CbGpPWpGaD
Eplerenone—Nausea—Epirubicin—uterine cancer	1.85e-05	0.000453	CcSEcCtD
Eplerenone—Vomiting—Doxorubicin—uterine cancer	1.84e-05	0.000449	CcSEcCtD
Eplerenone—Rash—Doxorubicin—uterine cancer	1.82e-05	0.000445	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—uterine cancer	1.82e-05	0.000444	CcSEcCtD
Eplerenone—Headache—Doxorubicin—uterine cancer	1.81e-05	0.000442	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—SMAD3—uterine cancer	1.81e-05	0.00138	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AKR1C3—uterine cancer	1.8e-05	0.00138	CbGpPWpGaD
Eplerenone—Nausea—Doxorubicin—uterine cancer	1.72e-05	0.000419	CcSEcCtD
Eplerenone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.69e-05	0.00129	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.59e-05	0.00122	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.57e-05	0.0012	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.48e-05	0.00113	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—ESR1—uterine cancer	1.47e-05	0.00113	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP19A1—uterine cancer	1.4e-05	0.00107	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—STK11—uterine cancer	1.4e-05	0.00107	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—STAR—uterine cancer	1.35e-05	0.00103	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.35e-05	0.00103	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.35e-05	0.00103	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.35e-05	0.00103	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.32e-05	0.00101	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.26e-05	0.00096	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.17e-05	0.000894	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.15e-05	0.000882	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—POLD1—uterine cancer	1.06e-05	0.000811	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—MTHFR—uterine cancer	1.05e-05	0.000806	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKR1C1—uterine cancer	9.92e-06	0.000759	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—STAR—uterine cancer	9.77e-06	0.000747	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKR1B1—uterine cancer	9.77e-06	0.000747	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.29e-06	0.00071	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—RRM2—uterine cancer	8.84e-06	0.000676	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—DCN—uterine cancer	8.58e-06	0.000656	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP11A1—uterine cancer	8.09e-06	0.000618	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—POLD1—uterine cancer	7.66e-06	0.000586	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKR1C3—uterine cancer	7.64e-06	0.000584	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKR1C1—uterine cancer	7.17e-06	0.000548	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—RRM2—uterine cancer	6.39e-06	0.000489	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SRD5A2—uterine cancer	6.28e-06	0.00048	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NDUFB11—uterine cancer	6.28e-06	0.00048	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—DCN—uterine cancer	6.2e-06	0.000474	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—STK11—uterine cancer	5.95e-06	0.000455	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP19A1—uterine cancer	5.95e-06	0.000455	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTEN—uterine cancer	5.86e-06	0.000449	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP11A1—uterine cancer	5.84e-06	0.000447	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—EP300—uterine cancer	5.59e-06	0.000428	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKR1C3—uterine cancer	5.52e-06	0.000422	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—AKT1—uterine cancer	5.32e-06	0.000407	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.54e-06	0.000347	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—STAR—uterine cancer	4.54e-06	0.000347	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MTHFR—uterine cancer	4.47e-06	0.000342	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—STK11—uterine cancer	4.3e-06	0.000329	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP19A1—uterine cancer	4.3e-06	0.000329	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CA—uterine cancer	4.14e-06	0.000316	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—POLD1—uterine cancer	3.56e-06	0.000273	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AKT1—uterine cancer	3.38e-06	0.000258	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.33e-06	0.000255	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MTHFR—uterine cancer	3.23e-06	0.000247	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—RRM2—uterine cancer	2.97e-06	0.000227	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—DCN—uterine cancer	2.88e-06	0.000221	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.72e-06	0.000208	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.57e-06	0.000196	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTEN—uterine cancer	2.49e-06	0.00019	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—EP300—uterine cancer	2.37e-06	0.000181	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP19A1—uterine cancer	2e-06	0.000153	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—STK11—uterine cancer	2e-06	0.000153	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTEN—uterine cancer	1.8e-06	0.000137	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.75e-06	0.000134	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—EP300—uterine cancer	1.71e-06	0.000131	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MTHFR—uterine cancer	1.5e-06	0.000115	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKT1—uterine cancer	1.43e-06	0.00011	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.27e-06	9.7e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKT1—uterine cancer	1.04e-06	7.92e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTEN—uterine cancer	8.36e-07	6.39e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—EP300—uterine cancer	7.97e-07	6.1e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.9e-07	4.51e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKT1—uterine cancer	4.82e-07	3.68e-05	CbGpPWpGaD
